Carmat SA (EPA:ALCAR)

Market Cap	18.77M
Revenue (ttm)	7.34M
Net Income (ttm)	-51.40M
Shares Out	56.80M
EPS (ttm)	-1.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,051,675
Average Volume	560,215
Open	0.3950
Previous Close	0.3895
Day's Range	0.3200 - 0.3950
52-Week Range	0.2300 - 2.9900
Beta	1.45
RSI	16.92
Earnings Date	Sep 10, 2025

About Carmat

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 153
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALCAR

Financial Performance

In 2024, Carmat's revenue was 7.34 million, an increase of 91.40% compared to the previous year's 3.84 million. Losses were -51.40 million, -4.59% less than in 2023.